PineBridge Investments’s Maravai LifeSciences MRVI Stock Holding History

PineBridge Investments’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,624	Closed	-$247K	–	916
2023 Q1	$247K	Sell	17,624 -32,270	-65%	-$463K	﹤0.01%	477
2022 Q4	$714K	Buy	49,894 +38,920	+355%	+$613K	0.01%	433
2022 Q3	$280K	Buy	10,974 +3,754	+52%	+$94.2K	﹤0.01%	454
2022 Q2	$205K	Buy	+7,220	New	+$229K	﹤0.01%	485

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PineBridge Investments's MRVI Position: Q2 2023 in Review

PineBridge Investments sold out of Maravai LifeSciences (MRVI) in Q2 2023, closing a stake of 17,624 shares — an estimated $247K sold.

PineBridge Investments first reported a position in MRVI in Q2 2022 and held it in 4 quarters. The position peaked at $714K in Q4 2022. 221 funds tracked by Wall St. Rank hold MRVI as of Q2 2023.

PineBridge Investments reported no remaining Maravai LifeSciences position as of Q2 2023 after selling out during the quarter.
PineBridge Investments sold 17,624 Maravai LifeSciences shares in Q2 2023, an estimated $247K.
PineBridge Investments first reported a position in Maravai LifeSciences in Q2 2022 and held it in 4 quarters.
PineBridge Investments's Maravai LifeSciences position peaked at $714K in Q4 2022.
221 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2023.

Based on PineBridge Investments's 13F filing for Q2 2023, filed 11 Aug 2023.